October 28, 2024 / 11:40 IST
Reported Standalone quarterly numbers for Tatva Chintan Pharma Chem are:Net Sales at Rs 80.96 crore in September 2024 down 12.54% from Rs. 92.57 crore in September 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 1.11 crore in September 2024 down 113.54% from Rs. 8.20 crore in September 2023.
EBITDA stands at Rs. 5.40 crore in September 2024 down 74.88% from Rs. 21.50 crore in September 2023.
Tatva Chintan shares closed at 914.95 on October 24, 2024 (NSE) and has given -26.49% returns over the last 6 months and -37.23% over the last 12 months.
| Tatva Chintan Pharma Chem | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'24 | Jun'24 | Sep'23 | | Net Sales/Income from operations | 80.96 | 93.81 | 92.57 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 80.96 | 93.81 | 92.57 | | EXPENDITURE | | Consumption of Raw Materials | 39.29 | 41.52 | 46.37 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 3.48 | 10.51 | -11.72 | | Power & Fuel | -- | -- | -- | | Employees Cost | 12.94 | 12.70 | 14.07 | | Depreciation | 6.81 | 6.66 | 6.78 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 20.65 | 21.39 | 23.12 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -2.21 | 1.03 | 13.97 | | Other Income | 0.81 | 1.42 | 0.76 | | P/L Before Int., Excpt. Items & Tax | -1.41 | 2.45 | 14.72 | | Interest | 0.17 | 0.31 | 3.01 | | P/L Before Exceptional Items & Tax | -1.58 | 2.14 | 11.71 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -1.58 | 2.14 | 11.71 | | Tax | -0.47 | 0.63 | 3.50 | | P/L After Tax from Ordinary Activities | -1.11 | 1.51 | 8.20 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -1.11 | 1.51 | 8.20 | | Equity Share Capital | 23.39 | 23.39 | 23.39 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.47 | 0.64 | 3.63 | | Diluted EPS | -0.47 | 0.64 | 3.63 | | EPS After Extra Ordinary | | Basic EPS | -0.47 | 0.64 | 3.63 | | Diluted EPS | -0.47 | 0.64 | 3.63 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
